Skip to content
Updates & Evolving Care Considerations in the Mitigation of Hyperkalemia in Patients with End-Stage Renal Disease on Dialysis - Case Review #1 Evaluation (ID: i785-5)
*
1.
How many years have you been in practice?
(Required.)
>21
11-20
1-10
<1
*
2.
How many patients with CKD and anemia do you manage?
(Required.)
1 to 25
26 to 50
51 to 100
100+
I am not directly involved in patient care
3.
Please select the option that best describes your practice setting.
Academic medical center
Community hospital or medical center
VA, DOD or other government
Managed Care
Research
Pharmaceutical industry
*
4.
After participating in this activity, how confident are you in the mitigation of Hyperkalemia in Patients with End-Stage Renal Disease on Dialysis in your practice?
(Required.)
Very confident
Confident
Neutral
Little confidence
No confidence
5.
How committed are you to making changes in your practice based on your participation in this activity?
Very committed
Committed
Neutral
Not committed
I do not plan to make changes
If not committed or do not plan to make changes, please indicate reason
6.
Which of the following best describes the impact of this activity on your performance?
I gained new strategies/skills/information I can apply to my area of practice
I need more information before I can change my practice
My practice is already consistent with the information presented
This activity will not change my practice
*
7.
Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.
(Required.)
Now I can describe the associated morbidity & mortality burdens & factors & exposures that increase the risk of hyperkalemia in patients with ESRD
I am able to integrate current evidence-based standards of care & prescribing information to individualize treatment for hyperkalemia in patients with ESRD on HD
*
8.
What barriers do you see to making changes in your practice?
(Required.)
Lack of knowledge regarding evidence-based strategies
Lack of convincing evidence to warrant change
Lack of time/resources to consider change
Insurance, reimbursement or legal issues
Conflicting guidelines or evidence
Patient compliance and/or patient resource barriers
Other (please explain)
*
9.
Please rate your level of agreement by checking the appropriate rating
After participating in today’s activity, I am now better able to:
(Required.)
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Describe the associated morbidity & mortality burdens & factors & exposures that increase the risk of hyperkalemia in patients with ESRD
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Integrate current evidence-based standards of care & prescribing information to individualize treatment for hyperkalemia in patients with ESRD on HD
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
*
10.
Please rate your level of agreement by checking the appropriate rating
George Bakris, MD, effectively:
(Required.)
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Presented the Material
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Avoided Commercial Bias
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
*
11.
Please rate your level of agreement by checking the appropriate rating
Matha Gulati, MD, effectively:
(Required.)
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Presented the Material
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Avoided Commercial Bias
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
*
12.
The content presented:
(Required.)
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Enhanced my current knowledge base
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Addressed my most pressing questions
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Promoted improvements or quality in health care
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Was scientifically rigorous and evidence based
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
Avoided commercial bias or influence
Strongly agree
Agree
Neutral
Disagree
Strongly disagree
13.
As a result of your participation in this activity, what is the one change you are most likely to implement in your practice?
14.
Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities.
15.
If you indicated that you perceived commercial bias or influence, please describe.